[1]Nissanka Rajapakse, Elisabete Silva, and Andreas Kortenkamp
Centre for Toxicology, School of Pharmacy, London, United Kingdom
Abstract
The low potency of many man-made estrogenic chemicals, so-called xenoestrogens, has been used to suggest that risks arising from exposure to individual chemicals are negligible. Another argument used to dismiss concerns of health effects is that endogenous steroidal estrogens are too potent for xenoestrogens to contribute significantly to estrogenic effects. Using a yeast reporter gene assay with the human estrogen receptor , we tested these ideas experimentally by assessing the ability of a combination of 11 xenoestrogens to affect the actions of 17ß-estradiol. Significantly, each xenoestrogen was present at a level well below its no-observed-effect concentration (NOEC). To derive accurate descriptions of low effects, we recorded concentration-response relationships for each xenoestrogen and for 17ß-estradiol. We used these data to predict entire concentration-response curves of mixtures of xenoestrogens with 17ß-estradiol, assuming additive combination effects. Over a large range of concentrations, the experimentally observed responses decisively confirmed the model predictions. The combined additive effect of the 11 xenoestrogens led to a dramatic enhancement of the hormone's action, even when each single agent was present below its NOEC. Our results show that not even sub-NOEC levels of xenoestrogens can be considered to be without effect on potent steroidal estrogens when they act in concert with a large number of similarly acting chemicals. It remains to be seen to what degree these effects can be neutralized by environmental chemicals with antiestrogenic activity. Nevertheless, potential human and wildlife responses induced by additive combination effects of xenoestrogens deserve serious consideration. Key words: 17ß-estradiol, additivity, mixture effects, xenoestrogens, yeast estrogen screen (YES). Environ Health Perspect 110:917-921 (2002). [Online 12 August 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p917-921rajapakse/abstract.html
Address correspondence to A. Kortenkamp, Centre for Toxicology, School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX UK. Telephone/Fax: +44 20 7753 5908. E-mail: andreas.kortenkamp@ulsop.ac.uk We thank J. Sumpter and N. Beresford, Brunel University, UK, for providing the recombinant yeast cells.
E.S. is funded by Programa Praxis XXI, Fundação para a Ciência e Tecnologia, Portugal, and N.R. is funded by a School of Pharmacy studentship.
Received 15 January 2002; accepted 8 March 2002.
However, the perceived "weakness" (or otherwise) of a xenoestrogen alone does not necessarily signal absence of risks, when considering the effects of xenoestrogens in relation to potent steroidal estrogens. In a recent study of mixtures of estradiol and the weak xenoestrogens bisphenol A and o,p´-DDT (Rajapakse et al. 2001), we found that both the hormone and the xenoestrogens contributed in equal measure to the observed combination effects when combined at concentrations that produced similar responses. Furthermore, model calculations carried out by our group suggested that combinations of a large number of xenoestrogens might modulate the effects of 17ß-estradiol, even when each individual xenoestrogen is present at concentrations that alone would not produce measurable effects (Kortenkamp and Altenburger 1999). In view of the implications for hazard assessment, we set out to test this idea experimentally.
Mixture experiments involving a large number of chemicals place very high demands on the reproducibility of biologic responses. To meet these requirements, we used the yeast estrogen screen (YES) (Routledge and Sumpter 1996), which has proven to yield highly reproducible results (Payne et al. 2000; Rajapakse et al. 2001).
Before we could proceed with the studies presented here, we had to investigate whether weak xenoestrogens, in the absence of the potent hormone 17ß-estradiol, would act together when combined at levels below no-observed-effect concentrations (NOECs). Furthermore, information about the validity of a variety of concepts for the prediction and assessment of xenoestrogen mixture effects was required. In a recent study involving eight weak xenoestrogens and the YES assay, we addressed these points (Silva et al. 2002). We were able to show that significant mixture effects occurred when the chemicals were mixed at levels equal to 50% of their individual NOEC. The effects of combinations of estrogenic chemicals were predicted on the basis of concentration-response relationships of individual mixture components ("fixed mixture ratio design") (Altenburger et al. 2000; Backhaus et al. 2000). We found that the additivity predictions calculated by using the concept of concentration addition (CA) (Loewe and Muischnek 1926) proved to agree excellently with experimental observations. In contrast, the competing concept of independent action (Bliss 1939) led to considerable underestimations of measured effects (Silva et al. 2002). Thus, CA can be used with confidence for the prediction and assessment of the joint effects of xenoestrogens in the YES assay. When dealing with agents that exhibit sigmoidal concentration-response curves, as is the case with estrogenic chemicals, it is not possible to calculate expected additive effects by forming the arithmetic sum of individual responses (effect summation; ES). Although the pitfalls of this approach have been discussed extensively (Berenbaum 1985; Kortenkamp and Altenburger 1998; Payne et al. 2000), its shortcomings are not widely acknowledged. For this reason, we have included ES here for purposes of comparison.
The clarification of the above issues provided a firm basis for the studies presented here. We created a pool of 11 weak xenoestrogens with a mixture ratio in proportion to the EC01 (concentration producing 1% of the maximally inducible effect in the YES assay) of all individual components. This ensured that no single xenoestrogen contributed disproportionately to the overall mixture effect. The 11 xenoestrogens were in turn mixed with 17ß-estradiol at defined mixture ratios, ranging from 1:25,000 to 1:100,000 (17ß-estradiol:pool of xenoestrogens). Predictions were calculated by using CA and then tested experimentally.
We determined concentrations of test agents that failed to produce measurable effects relative to untreated yeast by establishing NOECs and by using regression-based approaches that estimate low effects by interpolation on the basis of entire dose-response curves (benchmark concentrations) (Moore and Caux 1997; Van der Hoeven 1997). We have approximated "insignificant effects" as EC01 values.
Finally, it was necessary to restrict the selection of test agents to those that produced a maximal response similar to 17ß-estradiol. The reason for this constraint lies in the mathematical features of the CA concept: CA estimates concentrations of mixtures (and single agents) associated with predetermined effect levels. With estrogenic chemicals that yield only submaximal effects at saturating concentrations, this would have led to mixture effect prediction curves not exceeding the lowest maximal effect of any single mixture component. In many cases this might have complicated the assessment of agreement between experimental observation and predicted mixture effects. To avoid such ambiguities, we used only xenoestrogens with maximal effects of at least 60% of that seen with 17ß-estradiol in mixture studies.
The recombinant yeast estrogen screen. We followed a protocol developed by Routledge and Sumpter (1996) exactly as described by Rajapakse et al. (2001). We obtained single-agent data from at least three experiments run in duplicate, and mixture samples were run in duplicate on at least two separate occasions. Nominal concentrations were used.
Dosimetry. We constructed scatter plots of corrected absorbance values (effect) versus log concentration and analyzed them using the best-fit approach (Scholze et al. 2000). We selected the best fit from a number of nonlinear regression models for final data analysis. In these studies, we used the asymmetric (or three-parameter) Hill function:
[1]
where Min and Max are the minimal and maximal observed effects, respectively; c is the concentration of test agent; EC50 is the concentration of test agent yielding half-maximal effects; and p is the slope parameter. The 95% confidence intervals (CIs) of the best estimate of mean effects were also calculated. Nonlinear curve fitting was carried out using SigmaPlot (version 5.0; SPSS Inc., Chicago, IL, USA).
Determinations of low effect concentrations. We used Dunnett's t-test (Dunnett 1955) to estimate NOECs. EC01 values were determined by interpolation using the best-fit regression model for each tested chemical.
Calculation of predicted mixture effects. After comprehensive concentration-response analysis of the single agents, the responses of mixtures of 17ß-estradiol with the xenoestrogen pool (i.e., all 11 chemicals combined in proportion to their EC01 values; Table 1) were predicted assuming additive combination effects. Despite the numerous reports highlighting the shortcomings of ES, it is still being applied incorrectly. For this reason, the expected effects for three mixture ratios were calculated using not only the appropriate concept of CA but also ES, in the hope of demonstrating experimentally its failure under these conditions. A detailed description of the concepts and their mathematical derivation was published by Rajapakse et al. (2001).
Table 1. Summary of asymmetric Hill parameters a for test agents in the YES.
Fraction in NOEC EC01 X50 Compoundsb XE mix c (µM) (µM)d (µM) p-Value Max 1. 17β-Estradiol — 1.15×10–5 2.3×10–5 1.8×10–4 2.273 1.657 2. 2´,3´,4´,5´-Tetrachlorobiphenyl-4-ol 0.0004 0.005 0.008 0.061 2.202 1.711 3. 2´,5´-Dichlorobiphenyl-4-ol 0.0009 0.011 0.011 0.060 2.699 1.713 4. 4´-Chlorobiphenyl-4-ol 0.0054 0.054 0.074 0.599 2.161 1.665 5. Genistein 0.0074 0.038 0.086 0.595 2.337 1.672 6. 2,4-Dihydroxybenzophenone 0.0144 0.073 0.124 0.702 2.617 1.713 7. Benzyl-4-hydroxyparabene 0.0102 0.116 0.130 0.787 2.519 1.703 8. 2,3,4,5-Tetrachlorobiphenyl 0.0159 0.295 0.177 4.921 1.324 1.493 9. Bisphenol A 0.0554 0.422 0.632 2.879 2.983 1.676 10. Resorcinol monobenzoate 0.1950 0.990 2.236 13.49 2.546 1.765 11. 2,3,4-Trichlorobiphenyl 0.1592 1.501 2.420 30.13 1.755 1.522 12. Phenyl salicylate 0.5360 9.486 8.824 53.66 2.355 1.232 13. Sum (excluding 1) 1.000 13 14.7 — — — Abbreviations, Max, maximum; XE, xenoestrogen. a Defined in “Materials and Methods”; absorbance units for Max. b Numbers correspond to those in Figure 1. c Proportion of each component in “xenoestrogen pool” before combining with estradiol at ratios described in the text. d Concentration producing effect 0.017 absorbance units (i.e., 1% of maximal response in YES).
Assessing mixture predictions. The validity of the predicted mixture effects was evaluated experimentally using 1:100,000, 1:50,000, and 1:25,000 (17ß-estradiol:xenoestrogen pool) mixtures. Master stock solutions (1 mM) were made and serially diluted to cover the range of concentrations modeled in the predictions.
The impact of xenoestrogens in mixtures with 17ß-estradiol becomes discernible when mixture effects are plotted in terms of the concentration of steroid hormone in the mixture, along with the dose-response curve of the hormone alone. A shift of the mixture dose-response curve to the left of the 17ß-estradiol curve represents the impact of the xenoestrogens. The modulation is considered significant when the 95% CIs for the mixture and 17ß-estradiol regressions do not overlap.
|
Figure 1. Concentration-response curves for the 11 xenoestrogens and 17ß-estradiol in the YES assay, showing the best-fit regression models (asymmetric Hill function). AU, absorbance units. Test agents: 1) 17ß-estradiol; 2) 2´,3´,4´,5´-tetrachlorobiphenyl-4-ol; 3) 2´,5´-dichlorobiphenyl-4-ol; 4) 4´-chlorobiphenyl-4-ol; 5) genistein; 6) 2,4-dihydroxbenzophenone; 7) benzyl-4-hydroxyparabene; 8) 2,3,4,5-tetrachlorobiphenyl; 9) bisphenol A; 10) resorcinol monobenzoate; 11) 2,3,4-trichlorobiphenyl; 12) phenyl salicylate.
Figure 2. Predicted and observed mixtures effects of mixtures of 17ß-estradiol and 11 xenoestrogens. AU: absorbance units. The xenoestrogens were pooled in proportion to their EC01 values before being combined with 17ß-estradiol at mixture ratios of (A) 1:100,000; (B) 1:50,000 and (C) 1:25,000 17ß-estradiol:xenoestrogen pool.
Figure 3. The impact of xenoestrogens on the effects of 17ß-estradiol (E2) in three mixtures: (A) 1:100,000, (B) 1:50,000, and C) 1:25,000 E2:xenoestrogen pool. AU, absorbance units. Best fits, with 95% confidence belts, to the experimentally observed mixture data are plotted in terms of the E2 concentrations, alongside the concentration-response curve for E2 alone. The arrows in (B) indicate the concentration and the corresponding effects highlighted in Figure 4.
Figure 4. The effects produced by each mixture component at the concentrations present in 5 µM of the 1:50,000 mixture. Also shown are the predicted mixture effects calculated by using ES and CA and the observed mixture effect (MIX). Test agents (individual concentration): 1) 17ß-estradiol (100 pM); 2) 2´,3´,4´,5´-tetrachlorobiphenyl-4-ol (1.9 nM); 3) 2´,5´-dichlorobiphenyl-4-ol (4.6 nM); 4) 4´-chlorobiphenyl-4-ol (26.9 nM); 5) genistein (37.1 nM); 6) 2,4-dihydroxbenzophenone (71.9 nM); 7) benzyl-4-hydroxyparabene (71.9 nM); 8) 2,3,4,5-tetrachlorobiphenyl (79.5 nM); 9) bisphenol A (276.4 nM); 10) resorcinol monobenzoate (974.7 nM); 11) 2,3,4-trichlorobiphenyl (795.9 nM); 12) phenyl salicylate (2.68 µM). Error bars indicate the upper 95% confidence limit of responses. In view of the good agreement between CA prediction and experimental observation (MIX) the combined effect of all agents may be called (concentration) additive.
|
Parameters of the regression models and the mixture ratio of the pool of the 11 xenoestrogens are summarized in Table 1.
Estimation of low effect concentrations. We have estimated low effect concentrations of all tested chemicals in two ways: a) NOECs were determined using Dunnett's test, and b) concentrations producing 1% of the maximum induced effect in the YES assay (i.e., 1% of 1.765 absorbance units, given by saturating concentrations of resorcinol monobenzoate) were calculated.
As shown in Table 1, the low effect concentrations estimated using the two methods agreed well, although the NOECs of most chemicals were slightly lower than their corresponding EC01.
Prediction and assessment of mixture effects. To avoid one xenoestrogen contributing disproportionately to the overall combination effect, we made a pool of xenoestrogens by mixing the agents in proportion to their EC01 values. In turn, we combined this "pool" with 17ß-estradiol at mixture ratios of 1:100,000, 1:50,000, and 1:25,000 (17ß-estradiol:xenoestrogen pool). On the basis of the relative prevalence of each chemical in the mixture and of their concentration-response relationships, we calculated mixture effect predictions using CA and ES. The predictions were computed assuming additive combination effects and then tested experimentally.
There was good agreement between observed combination effects and those predicted by the CA concept (Figure 2). Thus, the combined effect of all the xenoestrogens and 17ß-estradiol can be called additive. In line with expectation, the observed mixture concentration-response curves shifted to lower concentrations, as the relative amount of 17ß-estradiol increased (median effect concentrations were 6.2, 4.5, and 3.2 µM for the 1:100,000, 1:50,000, and 1:25,000 17ß-estradiol:xenoestrogen pool, respectively).
In contrast, the predictions calculated using ES consistently and systematically underestimated the experimentally observed combination effects, independent of effect level. Furthermore, ES was conspicuously unable to model the leveling off of responses usually seen at high concentrations. Using ES as the assessment model, we would have concluded, erroneously, that the xenoestrogen-estradiol mixtures acted synergistically, because the observed combination effects exceeded those predicted by ES.
Impact of xenoestrogens on the effects of 17ß-estradiol. Due to the high potency of 17ß-estradiol, it is conceivable that the observed effects of the xenoestrogen-estradiol mixtures were almost entirely due to the action of the steroid hormone. Whether or not this is the case is not immediately obvious from the plots of mixture effects against the total concentration of all mixture components shown in Figure 2. To delineate the effect of the hormone from the effects contributed by the xenoestrogen pool, we normalized the total mixture concentrations for 17ß-estradiol levels and plotted the observed responses against the 17ß-estradiol content of the mixtures. The resulting best-fit regression curves were then compared to that of the hormone on its own (Figure 3). If the xenoestrogens contributed significantly to the total combination effect, increases in response, resulting in displacements of the mixture curves toward lower concentrations, would be expected. The extent of this leftward shift relative to the 17ß-estradiol curve should be more pronounced, the higher the xenoestrogen content of the mixtures.
These expectations were borne out by our experimental observations. With all three mixtures, the contribution of the xenoestrogens revealed itself as a shift of the mixture concentration-response curves to the left of the 17ß-estradiol curve. This shift was most notable in the 1:100,000 mixture, in which the proportion of xenoestrogens was highest. Even with the 1:25,000 mixture, the xenoestrogens significantly modulated the action of the steroid hormone, judged by the lack of overlap of the respective 95% CIs of the best-fitted regression models.
Modulation of the effects of 17ß-estradiol by xenoestrogens at concentrations below individual NOECs. We became interested in comparing the joint effects of xenoestrogen-estradiol mixtures with the responses expected to occur after administration of each component at concentrations well below the individual NOEC. As shown by the data compiled in Table 1, the total mixture concentrations resulting from combining all 11 xenoestrogens and 17ß-estradiol at their NOECs or EC01 levels are 13 and 14.7 µM, respectively. Figure 4 shows the effect of 5 µM of the 1:50,000 mixture. This concentration was chosen because it lies on the linear portion of the mixture concentration-response curve and is the lowest tested concentration where the dose-response curves of the mixture and of 17ß-estradiol are parallel. Additionally, this concentration is well below the sum of the NOECs and EC01 values of the xenoestrogens in the mixture. We can therefore safely assume that none of the xenoestrogens would have produced effects detectable with the YES assay when applied singly at these levels.
Figure 4 also shows the responses expected to result from the levels of 17ß-estradiol present in the mixture. Crucially, combination with 11 weak xenoestrogens led to dramatic enhancements of mixture responses, although each of the 11 xenoestrogens was present at levels well below those that induce measurable responses. There was more than a doubling of effects relative to those of 17ß-estradiol.
It becomes immediately obvious from Figure 4 that calculation of combination effects by computing the arithmetic sum of individual responses (ES) led to dramatic underestimation of observed joint effects. In contrast, CA yielded a prediction that agreed well with experimental observation.
Perhaps the most striking finding of our study is the demonstration that large numbers of weak xenoestrogens are able to modulate significantly the effects of the potent steroidal estrogen 17ß-estradiol. This modulation occurred even when each individual xenoestrogen was present at levels that did not induce measurable effects, well below the individual NOEC and EC01 values. Although it may at first appear paradoxical, this phenomenon can be explained in terms of the premises of the CA concept. The concept assumes that all components of a mixture act in a similar way. From a pharmacologic point of view, they can be thought of as behaving as dilutions of one another. Thus, in interacting with the estrogen receptor, each component will add to the overall joint effect in proportion to its individual potency and its concentration. It follows that infinitesimally low concentrations of an agent will contribute to the mixture effect, even though, upon administration on its own, no response (zero effect) will be produced. If the number of agents is sufficiently large, their concentrations will combine to produce measurable responses. Provided these responses are sufficiently large, effect modulations of potent steroid estrogens will occur, as observed here. Simple addition of effects, as in the ES method, is unable to describe the behavior of mixtures of xenoestrogens and 17ß-estradiol (Figure 4) and will underestimate biologic responses (Berenbaum 1985; Kortenkamp and Altenburger 1999; Silva et al. 2002).
It was our intention to model a scenario in which all components of a mixture interact with the same receptor, the hERa, in the genetic context of the yeast cell reporter gene construct. Our results show clearly that under such conditions, not even concentrations below NOECs can be considered to be without effect on steroidal estrogens, provided exposure is to sufficiently large numbers of receptor agonists. Due to the characteristics of the YES assay, however, the influence of other signal transduction pathways and effector chains responsible for estrogen-related effects (and their inhibition) could not be captured. It is well recognized that the effects of steroid hormone receptor agonists/antagonists not only are determined by ligand-receptor binding but also depend on interactions with specific effector molecules (Katzenellenbogen et al. 1996). One class of such effectors, accessory proteins called coregulators, are able to modulate the transcriptional activity of steroid hormone receptors, even in the absence of classical ligands (reviewed by Robyr et al. 2000; Rosenfeld and Glass 2001). It remains to be seen how the convergence of ligand-dependent and -independent mechanisms in different cellular contexts might impact the joint effects of xenoestrogens and related compounds. Similar considerations apply to the possible antagonizing effects of chemicals such as coplanar polychlorinated biphenyls, dioxins, and furans. These agents may oppose the effects of estrogenic chemicals by down-regulating ERa expression, up-regulating 17ß-estradiol-metabolizing enzymes, and altering the expression of estrogen-inducible genes (Gillesby and Zacharewski 1998). It will be revealing to investigate whether such effects occur at environmentally relevant concentrations.
Taken together, our findings from this and previous studies allow several interconnected conclusions to be drawn. First, the biologic effects of xenoestrogens cannot be dismissed as insignificant solely on the basis of their low potency compared with steroidal estrogens. Considered in isolation, the contribution of individual xenoestrogens at the concentrations found in wildlife and human tissues will always be small. However, such reasoning cannot be used to support claims of negligible health risks from weak xenoestrogens, because the number of xenoestrogens present in wildlife and humans is unknown but likely to be very large. Whether there are risks associated with xenoestrogens depends also on the influence of chemicals that antagonize estrogenic effects. It remains to be seen whether these chemicals, at environmentally relevant concentrations, are able to neutralize the effects of xenoestrogens.
Second, the fascination with synergistic effects that has gripped the endocrine disruptor field in the wake of the paper by Arnold et al. (1996) is misguided. It has led to a disregard of the significance of seemingly unspectacular additive combination effects. Our results show clearly that additivity is important and deserves serious attention in the assessment of chemicals with estrogenic activity.
Third, by not taking combination effects into account, significant underestimations of the effects associated with exposure to xenoestrogens are likely. In our experimental model, we have demonstrated in principle that every xenoestrogen, however weak, may add incrementally to the total estrogenic effect, even at very low concentrations, and even in the presence of potent endogenous steroidal estrogens. Although the limitations of our assay system are obvious (it is unable to model antiestrogenic effects and transcriptional activation in different cellular contexts), it is safe to conclude that the discourse about endocrine disruptors cannot be limited to single agents and their effects. There have been reports of low-dose effects of estrogenic chemicals (Howdeshell et al. 1999; vom Saal et al. 1997). In most cases, however, the outcome of single-agent hazard and risk assessment exercises is the conclusion that individual estrogenic chemicals pose no hazard because they are present at very low, apparently ineffective levels in humans and wildlife. A more balanced approach to risk assessment is required. It is imperative to take stock of the total estrogenic burden of humans and wildlife and assess systematically the possible influence of environmentally relevant agents that may have the ability to neutralize the effects of estrogens.
References and Notes
Altenburger R, Backhaus T, Boedeker W, Faust M, Scholze M, Grimme LH. 2000. Predictability of the toxicity of multiple chemical mixtures to Vibrio fischeri: mixtures composed of similarly acting chemicals. Environ Toxicol Chem 19:2341-2347.
Arnold SF, Klotz DM, Collins BM, Vonier PM, Guilette LJ Jr, McLachlan JA. 1996. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272:1489-1492.
Ashby J, Lefevre PA, Odum J, Harris CA, Routledge EJ, Sumpter JP. 1997. Synergy between synthetic oestrogens? [Letter]. Nature 385:494.
Backhaus T, Altenburger R, Boedeker W, Faust M, Scholze M, Grimme LH. 2000. Predictability of the toxicity of a multiple mixture of dissimilarly acting chemicals in Vibrio fischeri. Environ Toxicol Chem 19:2348-2356.
Berenbaum MC. 1985. What is synergy? Pharmacol Rev 41:93-141.
Bliss CI. 1939. The toxicity of poisons applied jointly. Ann Appl Biol 26:585-615.
Dunnett CW. 1955. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096-1121.
Gillesby BE, Zacharewski TR. 1998. Exoestrogens: mechanisms of action and strategies for identification and assessment. Environ Toxicol Chem 17:3-14.
Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. 1999. Exposure to bisphenol A advances puberty. Nature 401:763-764.
Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS. 1996. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10:119-131.
Kortenkamp A, Altenburger R. 1998. Synergisms with mixtures of environmental estrogens: a reevaluation using the method of isoboles. Sci Total Environ 221:59-73.
------. 1999. Approaches to assessing combination effects of oestrogenic environmental pollutants. Sci Total Environ 233:131-140.
Loewe S, Muischnek H. 1926. Über Kombinationswirkungen [in German]. 1. Mitteilung: Hilfsmittel der Fragestellung. Naunyn-Schmiedebergs. Arch Exp Pathol Pharmakol 114:313-326.
McLachlan JA. 1997. Synergistic effect of environmental estrogens: report withdrawn. Science 277:462-463.
Miller D, Wheals BB, Beresford N, Sumpter JP. 2001. Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay. Environ Health Perspect 109:133-139.
Moore CRJ, Caux PY. 1997. Estimating low toxic effects. Environ Toxicol Chem 16:794-801.
Payne J, Rajapakse N, Wilkins M, Kortenkamp A. 2000. Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ Health Perspect 108:983-987.
Rajapakse N, Ong D, Kortenkamp A. 2001. Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicol Sci 60:296-304.
Ramamoorthy K, Wang F, Chen I, Norris JD, McDonnel DP, Leonard LS, et al. 1997. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism. Endocrinology 138:1520-1527.
Robyr D, Wolffe AP, Wahli W. 2000. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endrocrinol 14:329-347.
Rosenfeld MG, Glass CK. 2001. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276:36865-36868.
Routledge EJ, Sumpter JP. 1996. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem 15:241-248.
Safe SH. 1995. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect 103:346-351.
Scholze M, Boedeker W, Faust M, Backhaus T, Altenburger R, Grimme LH. 2000. A general best fit method for concentration-response curves and the estimation of low effect concentrations. Environ Toxicol Chem 20:448-457.
Silva E, Rajapakse N, Kortenkamp A. 2002. Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOEC's produce significant mixture effects. Environ Sci Technol 36:1751-1756.
Van der Hoeven N. 1997. How to measure no effect. Part 1: Towards a new measure of chronic toxicity in ecotoxicology. Introduction and workshop results. Environmetrics 8:255-261.
vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA, Nagel SC, et al. 1997. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA 94:2056-2061.
Last Updated: August 12, 2002
|
If you have come to this page from an outside location click here to get back to mindfully.org |
